Web31 Aug 2024 · The following case study is about lithium prescribing in secondary care. It shows the principles and approaches which are available to protect patient safety when prescribing and monitoring drugs with a narrow therapeutic window. The example is informed by guidance from NICE. NICE guidance is developed in and for England. WebLithium is a type of medicine known as a mood stabiliser. It's used to treat mood disorders such as: mania (feeling highly excited, overactive or distracted) hypo-mania (similar to mania, but less severe) regular periods of depression, where treatment with …
hfs.illinois.gov
WebNEWSLETTER HSCB Invests in Technology Solution to Enhance Medicines Optimisation New: Drug monitoring tool on SPS website Deprescribing: Vitamins (excluding Vitamin D) in Adults NICE Guidance — NI Service Notifications Managed Entry Decisions September 2024 Volume 12, Issue 9 Health and Social Care Board In This Issue ... Web8 Jul 2024 · Shared Care Protocols (SCPs) Shared Care Protocols are clinically focussed and provide the information required to support safe and effective shared care for the specified medicines. They include licensed indications and established off-label uses. Standardised templates will improve patient safety, reduce duplication and reduce … the maze district hiking trails book
Suggestions For Drug Monitoring in Adults in Primary …
WebLithium in pregnancy and breastfeeding Lithium in pregnancy and breastfeeding This is information is for any woman who is: Taking Lithium and wants to get pregnant. Taking Lithium and is pregnant. Pregnant and may need to start Lithium in pregnancy. Taking Lithium and wants to breastfeed Breastfeeding and may need to start Lithium. Web19 Dec 2024 · Lithium excretion into breastmilk and concentrations in infant serum are highly variable. Although lithium appears on some lists of drugs contraindicated during breastfeeding,[1] many sources do not consider it an absolute contraindication in healthy-full-term infants, especially in infants over 2 months of age and during lithium … Webmonitoring interval should be continued and extension is in most circumstances inappropriate SPS Extending blood monitoring intervals is not suitable if the patient has: - Elderly (over 65 years); - On Lithium <12 months; - eGFR <60ml/min; - initiating/stopping interacting drugs with lithium since last lithium test;U+E, -FBC, established CKD; the maze demille nelson